About us

Enhancing Drug Discovery with 3D HuBiogel Assays

Major Limitations of Traditional 2D Bioassays

• Does Not Mimic Tissue Environment: 2D assays fail to replicate the complex, three-dimensional environment found in living tissues, limiting their relevance for real-world applications.
• Poor Predictors of Drug Response: Due to their lack of spatial complexity, 2D models often fall short in accurately predicting how drugs will behave in the body.
• Aberrant Gene Expression: Cells in 2D bioassays may exhibit gene expression patterns that differ significantly from those in natural tissue environments, potentially skewing research results.

Advantages of the 3D HuBiogel Assay

• Permits ‘Mini-Tissue’ Formation: 3D HuBiogel assays allow cells to grow, self-organize, and function as they would in natural tissue, creating a more accurate model.
• Real-Time Morphological & Functional Analysis: This assay enables researchers to observe cell morphology and function in real time, providing insights that are closely aligned with in vivo conditions.
• In Vivo-Like Biomarkers & Gene Expression: Cells in HuBiogel assays exhibit biomarker profiles and gene expression similar to those in live tissues, making them powerful tools for predictive studies.

High-Value Utility for Drug Discovery

• Precise Drug Sensitivity & Toxicity Analysis: The 3D HuBiogel platform enhances the precision of drug response testing, making it invaluable for identifying effective drug candidates and avoiding toxic side effects.
• Rapid Preclinical Drug Evaluation: This assay enables faster evaluation of drug efficacy, streamlining the preclinical phase of drug discovery.
• Accelerated Functional Genomics & Proteomics Research: By mimicking tissue-like environments, 3D HuBiogel supports robust genomics and proteomics studies.
• Patient-Based Therapy Response & Biomarker Profiling: Personalized insights into patient-specific drug responses and biomarker profiling make the 3D assay a powerful tool in the development of targeted therapies.

Multi-Tissue Models for Comprehensive Research

• Normal & Disease ‘Mini-Tissue’ Models: HuBiogel enables the creation of both healthy and diseased tissue models, allowing for comprehensive studies on drug efficacy.
• In Vivo-Like Cellular & Molecular Endpoints: The assay reveals cellular behaviors and molecular endpoints that mirror those observed in live organisms.
• Parallel Drug Sensitivity & Tissue Toxicity Profiling: Researchers can conduct simultaneous assessments of drug effectiveness and potential tissue toxicity.
• Defined Bio-Scaffolds for Stem Cells & Tissue Repair: These bio-scaffolds provide a stable structure for stem cell growth, advancing tissue engineering and repair research.
• Long-Term Culture Studies of Patient-Derived Cells: HuBiogel supports extended studies of cells from patient biopsies, offering valuable insights for personalized medicine and chronic disease research.

The 3D HuBiogel assay is transforming drug discovery, offering a versatile, reliable platform that bridges the gap between in vitro and in vivo research, empowering scientists to make more accurate predictions and streamline drug development.